Navigation Links
Provista Awards Agreement to Spheris
Date:11/20/2007

Spheris to be the First Provider of Clinical Documentation Technology,

Services to Provista

FRANKLIN, Tenn., Nov. 20 /PRNewswire/ -- Spheris has been selected as the first awarded supplier of medical transcription technology and services by Provista, one of the nation's leading group purchasing organizations. Under the parties' agreement, Spheris will provide Provista customers with a full range of clinical documentation technologies in addition to industry-leading outsource services.

"We're excited about our relationship with Spheris and to be able to offer our customers quality medical transcription technology and services from one of the clear leaders in the industry," said Russell Hall, vice president of operations for Provista.

Provista serves more than 10,000 health care and education organizations nationwide, providing solutions to help its customers improve financial performance.

With a global network of 5,500 medical language specialists providing 24- hour service, 365 days a year, Spheris believes its blended approach of service and technology is unique in the clinical documentation industry. Spheris offers a comprehensive, customizable platform for clinical documentation technologies that is available as a stand-alone solution or can be combined with either full or partial outsourcing.

The agreement allows Provista customers to receive preferred pricing on the Spheris Clarity(TM) platform for clinical documentation. Spheris Clarity is a fully integrated suite of applications that is designed to meet the diverse needs of physicians and departments across a health system enterprise. By enabling users to work on the same platform, Spheris Clarity improves the accessibility, interoperability, efficiency and productivity of the clinical documentation process.

"This partnership agreement will allow Provista customers not only to benefit from Spheris' unique Follow the Sun(SM) service and technology offering and competitive pricing, but will also expedite the sales and implementation processes," said Alan Whorton, senior vice president of sales and marketing for Spheris.

About Spheris

Spheris is a leading global outsource provider of clinical documentation technology and services to more than 500 health systems, hospitals and group practices throughout the U.S. Spheris offers a highly advanced, Web-based technology platform, available as an independent solution to support in-house departments or blended with Spheris' outsource services. Spheris employs approximately 5,500 skilled medical language specialists supporting the company's clients through a secure network. Using a Follow the Sun(SM) service strategy, customer support is provided 24 hours a day, 365 days a year with an emphasis on verifiable quality, turnaround time and pricing. Spheris' corporate headquarters is located in Franklin, Tenn. For more information, please visit http://www.spheris.com.

About Provista

Provista is an Irving, Texas-based multi-industry group purchasing organization (GPO) serving more than 10,000 health care and higher education organizations across the nation. Provista is jointly owned by VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances. Additional information about Provista is available online at http://www.provistaco.com.


'/>"/>
SOURCE Spheris
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
2. CDC Awards NATT Funding to Improve Blood Clot Awareness
3. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
4. National Institutes of Health Awards $25.5M Contract to SRA
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
7. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
8. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
9. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
10. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
11. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Patient ... developed with Wi-Fi connectivity to reduce the amount of wiring in a healthcare ... addition, compact mobile devices including infusion pumps, heart and hypertension monitoring, glucose monitoring, ...
(Date:5/23/2017)... ... 2017 , ... Firmex today announced the general ... for organizations to send and gather large files and confidential documents beyond the ... size limitations. , Using the same market-tested infrastructure as Firmex’s flagship Virtual ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... source of human cardiovascular cells for research and the development of cardiac ... possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to varying differentiation ...
(Date:5/23/2017)... ... May 22, 2017 , ... NetDimensions has been ranked as ... Globe™ for Corporate Learning, 2017. , Aragon Research defines Leaders as organizations who ... perform against those strategies. NetDimensions’ ranking as a Leader due to its strengths ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):